Skip to main content
. 2022 Dec 6;23(23):15410. doi: 10.3390/ijms232315410
AIF Apoptosis-inducing factor
aSMase Acid sphingomyelinase
ATF6 Activating transcription factor 6
ATP Adenosine triphosphate
BER Base excision repair
CDDP Cisplatin
CHOP C/EMP homologous protein
CP Carboplatin
CRT Calreticulin
CTR1 High affinity copper uptake protein 1
Cyt C Cytochrome C
DAMP Damage-associated molecular patterns
DC Dendritic cell
DISC Death-inducing signalling complex
DSB Double strand breaks
ER Endoplasmic reticulum
ERCC1 Cross-complementation group 1
FasR Fas receptor
FDA US Food and Drug Administration
FOLFOX 5-fluorouracil, leucovorin, oxaliplatin drug combination
GEMOX Gemcitabine, oxaliplatin drug combination
GSH Glutathione
HCC Hepatocellular carcinoma
HMGB1 High-mobility group box 1
HR Homologous recombination
HSOS Hepatic sinusoidal obstruction syndrome
IAP Inhibitors of apoptosis proteins
ICD Immunogenic cell death
ICL Interstrand crosslink
IRE1α Inositol-requiring protein 1α
IROX Irinotecan, oxaliplatin drug combination
miRNA microRNA
MMR Mismatch repair
MRP Multidrug resistance proteins
mtDNA Mitochondrial DNA
nDNA Nuclear DNA
NPM1 Nucleophosmin
Nrf2 NF-E2-related factor 2
OCT Organic cation transporter
OIPN Oxaliplatin-induced peripheral neuropathy
OXP Oxaliplatin
pEIF2α Phosphorylated eukaryotic translation factor 2α
PERK Protein kinase RNA-like endoplasmic reticulum kinase
Pol I RNA Polymerase I
Pt Platinum
Pt Platinum
ROS Reactive oxygen species
rRNA Ribosomal RNA
ssDNA Single strand DNA breaks
SSRP1 structure specific recognition protein 1
TFIIH Transcription factor II H
TLR4 Toll-like receptor 4
UBF Upstream binding factor
XPC Xeroderma pigmentosum